This week’s decision to relocate the European Medicines Agency to Amsterdam has been greeted as the least damaging outcome for the European Union's medicines regulator, which must leave Lon
Amsterdam was chosen as the new home of the European Medicines Agency (EMA) yesterday in a high-drama selection process, which saw the decision come down to the
The decision on where the new home of the European Medicines Agency (EMA) will be is to be made today, and Bratislava, the capital of Slovakia, has emerged as the surprise favourite to win
In an industry growing as quickly as cell therapy, keeping up with the demands of manufacturing and treatment is a challenge for the whole industry to tackle together, including stakeholder
Drug discovery is usually a goal-driven and iterative process, as researchers look for innovative new routes to target particular diseases and study those diseases in afflicted patients to learn ho
